ACROBiosystems has successfully launched its Claudin family proteins, including
Claudin 18.2,
Claudin 18.1,
Claudin 1,
Claudin 6,
Claudin 4 and
Claudin 9, using its
FLAG technology, a series of multi-pass transmembrane protein development platforms. Claudins are a family of proteins that have been recently identified to play a role in oncogenesis and can assist in cancer prognosis. Generally, these full-length multi-pass transmembrane target antigens are difficult to prepare while maintaining their native conformation. However, through our technology, we offer full-length Claudin family proteins with high bioactivity and batch-to-batch consistency that is verified through ELISA, SPR, BLI, FACS, and other methods, to support your innovative drug research and development.
We also provide corresponding stable cell line products and
cell line development service
to facilitate drug development and clinical submission. Welcome to inquiry~